Everest Group

EGNYSEUSD

THESIS ALERT

Email me when the EG thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$423.74
+$1.42 (+0.34%)Today 1M +14.65%
After hours$423.740.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$422.32
Prior regular-session close from the quote source.
$417.00–$423.98
Regular-session low and high so far today.
399.1K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$304.55–$431.19
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own EG if Everest is a capital‑intensive, A+‑rated re/insurer whose value derives from underwriting expertise, a strong balance sheet that supports market access and pricing, and active reserve and capital management to smooth cycle volatility.

EG price history

Latest price$423.74Today+$1.42 (+0.34%)
EG +13.54%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Everest’s strong capital base (shareholders’ equity) and A+ ratings give it the capacity and distribution access to win treaty reinsurance and preserve pricing power through underwriting cycles.StrengtheningMateriality: High

    equity increased to $15,461,000,000 (2025) from $13,875,000,000 (2024) (fundamentals). If true, Everest can grow or maintain profitable premium volumes without forced capital raises; if false, it will be priced out of profitable deals or face rating pressure that raises capital costs and depresses margins.

    Watch: A material catastrophe or sequence of losses that materially erode equity and force asset sales or capital raises.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    equity increased to $15,461,000,000 (2025) from $13,875,000,000 (2024) (fundamentals).

    Open source ↗
  • By transferring in‑the‑money reserves and buying an adverse development cover (ADC), management has materially reduced the near‑term risk of prior‑year reserve surprises for North American Insurance liabilities, which should dampen earnings volatility.HoldingMateriality: High

    NET_INCOME of $1,591,000,000 for 2025 despite unfavorable prior‑year development of $657 million (MD&A). If reserve volatility falls, reported earnings and ROE become more predictable and the stock rerates; if reserve shocks recur (especially in excluded pools), earnings will remain volatile and capital will be consumed.

    Watch: Material adverse development emerging in reserves excluded from the ADC (e.g., run‑off Asbestos & Environmental exposures).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    NET_INCOME of $1,591,000,000 for 2025 despite unfavorable prior‑year development of $657 million (MD&A).

    Open source ↗
  • Refocusing toward reinsurance and wholesale/specialty (and selling certain renewal rights) will improve underwriting mix and reduce volatility, supporting higher EPS per share over time.HoldingMateriality: Medium

    eps_diluted rose to $37.80 in 2025 from $31.78 in 2024 (fundamentals) despite reserve actions. A mix shift to higher‑margin reinsurance could lift EPS and ROE (and justify a higher multiple); if the sale simply swaps current earnings for lower future premium base, EPS could fall.

    Watch: The sold renewal rights represent recurring future premiums and margins that, once ceded, reduce long‑term earnings power.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    eps_diluted rose to $37.80 in 2025 from $31.78 in 2024 (fundamentals) despite reserve actions.

    Open source ↗
  • A meaningful net investment income stream provides a floor to profitability and helps offset underwriting variability in weak rate environments.HoldingMateriality: Medium

    Total revenues of $17,496,000,000 in 2025 included net investment income of $2,124,000,000 (MD&A/financial summary). If investment income remains supportive, combined results are more resilient; if investment returns deteriorate or realize losses increase, underwriting weakness will more easily push earnings negative.

    Watch: Significant realized losses on the investment portfolio (mark‑to‑market declines or impairments) that reverse the income benefit.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Total revenues of $17,496,000,000 in 2025 included net investment income of $2,124,000,000 (MD&A/financial summary).

    Open source ↗
  • Everest will continue to generate material operating cash flow to fund reserve strengthening, reinsurance purchases and potential capital returns, provided underwriting and reserve trends stabilize.HoldingMateriality: Medium

    operating_cash_flow was $3,068,000,000 in 2025 (fundamentals), and historically higher in prior years (e.g., $4,957,000,000 in 2024). Sustained positive operating cash flow enables buybacks/dividends and avoids dilutive capital raises; a collapse in cash flow would force hard choices on capital and underwriting appetite.

    Watch: Further reserve strengthening or catastrophic loss years that materially reduce operating cash flow and exhaust liquidity.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    operating_cash_flow was $3,068,000,000 in 2025 (fundamentals), and historically higher in prior years (e.g., $4,957,000,000 in 2024).

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Everest’s strong capital base (shareholders’ equity) and A+ ratings give it the capacity and distribution access to win treaty reinsurance and preserve pricing power through underwriting cycles. If true, Everest can grow or maintain profitable premium volumes without forced capital raises; if false, it will be priced out of profitable deals or face rating pressure that raises capital costs and depresses margins.

By transferring in‑the‑money reserves and buying an adverse development cover (ADC), management has materially reduced the near‑term risk of prior‑year reserve surprises for North American Insurance liabilities, which should dampen earnings volatility. If reserve volatility falls, reported earnings and ROE become more predictable and the stock rerates; if reserve shocks recur (especially in excluded pools), earnings will remain volatile and capital will be consumed.

Refocusing toward reinsurance and wholesale/specialty (and selling certain renewal rights) will improve underwriting mix and reduce volatility, supporting higher EPS per share over time. A mix shift to higher‑margin reinsurance could lift EPS and ROE (and justify a higher multiple); if the sale simply swaps current earnings for lower future premium base, EPS could fall.

A meaningful net investment income stream provides a floor to profitability and helps offset underwriting variability in weak rate environments. If investment income remains supportive, combined results are more resilient; if investment returns deteriorate or realize losses increase, underwriting weakness will more easily push earnings negative.

Everest will continue to generate material operating cash flow to fund reserve strengthening, reinsurance purchases and potential capital returns, provided underwriting and reserve trends stabilize. Sustained positive operating cash flow enables buybacks/dividends and avoids dilutive capital raises; a collapse in cash flow would force hard choices on capital and underwriting appetite.

All standing thesis claims
Original report summary

Everest is a capital‑intensive, A+‑rated re/insurer whose value derives from underwriting expertise, a strong balance sheet that supports market access and pricing, and active reserve and capital management to smooth cycle volatility.

Evidence assessed Nov 7, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Everest Group

Where the evidence on Everest Group stands: Holding on the latest evidence (Nov 7, 2026). Of its 5 thesis points, 1 strengthening and 4 holding.

Bull case: what the evidence supports

  • Everest’s strong capital base (shareholders’ equity) and A+ ratings give it the capacity and distribution access to win treaty reinsurance and preserve pricing power through underwriting cycles.

    sec.gov ↗

  • By transferring in‑the‑money reserves and buying an adverse development cover (ADC), management has materially reduced the near‑term risk of prior‑year reserve surprises for North American Insurance liabilities, which should dampen earnings volatility.

    sec.gov ↗

  • Refocusing toward reinsurance and wholesale/specialty (and selling certain renewal rights) will improve underwriting mix and reduce volatility, supporting higher EPS per share over time.

    sec.gov ↗

  • A meaningful net investment income stream provides a floor to profitability and helps offset underwriting variability in weak rate environments.

    sec.gov ↗

  • Everest will continue to generate material operating cash flow to fund reserve strengthening, reinsurance purchases and potential capital returns, provided underwriting and reserve trends stabilize.

    sec.gov ↗

Bear case: what would count against it

  • A material catastrophe or sequence of losses that materially erode equity and force asset sales or capital raises.

    sec.gov ↗

  • Material adverse development emerging in reserves excluded from the ADC (e.g., run‑off Asbestos & Environmental exposures).

    sec.gov ↗

  • The sold renewal rights represent recurring future premiums and margins that, once ceded, reduce long‑term earnings power.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Everest Group

Loading the break-condition record for Everest Group.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    Everest Group filed an SEC 8-K on 2026-10-28: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Regulation FD disclosure.

    Everest Group filed an SEC 8-K on 2026-10-19: Regulation FD disclosure. It is a dated development that tests the current thesis.

  3. Mixed
    Regulation FD disclosure.

    Everest Group filed an SEC 8-K on 2026-08-31: Regulation FD disclosure. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • A material catastrophe or sequence of losses that materially erode equity and force asset sales or capital raises.
  • Material adverse development emerging in reserves excluded from the ADC (e.g., run‑off Asbestos & Environmental exposures).
  • The sold renewal rights represent recurring future premiums and margins that, once ceded, reduce long‑term earnings power.
  • Significant realized losses on the investment portfolio (mark‑to‑market declines or impairments) that reverse the income benefit.
  • Further reserve strengthening or catastrophic loss years that materially reduce operating cash flow and exhaust liquidity.

EG news

Loading headlines…

Financial statements

EG income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

EG: quick answers

Which well-known investors own EG?
1 of the 37 well-known funds tracked here reported EG shares in their latest 13F filing. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.1%. Fund portfolios

EG in well-known investors’ portfolios

1 of 37 funds reported EG shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Ray DalioBridgewater Associates0.11%$25.8M+310.6%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.